Côme Tholomier, Roger Valdivieso, Pierre-Alain Hueber, Kevin C. Zorn

Canadian Journal of Urology, Vol.22, Suppl.5, pp. 45-52, 2015

Abstract instruction: Introduction: Transurethral resection of the prostate (TURP) is still considered the gold standard to treat benign prostatic hyperplasia (BPH). However, photoselective vaporization of the prostate (PVP) has gained widespread acceptance as an alternative option requiring preoperative patient selection. Four laser systems are currently in use: holmium, thulium, diode and GreenLight.
instruction: Materials and methods: The goal of this article is to review the physics and the basics behind laser prostatectomies, as well as to present the most current literature concerning the results, advantages, disadvantages and international recommendations for each vaporization procedure.
instruction: Results: Holmium laser ablation of… More >

Rodrigo Donalisio da Silva^1,*, Luke Bidikov^1,2,*, Walker Michaels¹, Diedra Gustafson¹, Wilson R. Molina^1,2, Fernando J. Kim^1,2

Canadian Journal of Urology, Vol.22, Suppl.5, pp. 30-44, 2015

Abstract instruction: Introduction: For decades, the monopolar transurethral resection of the prostate has been established as the minimally invasive surgical treatment for patients with benign prostatic hyperplasia (BPH). In recent years, new technologies and devices emerged to reduce the morbidity and improve outcomes for this treatment approach. Bipolar energy introduced the use of saline irrigation and laser technology increased the urological armamentarium to treat BPH. We performed a systematic review of the literature regarding bipolar technology for the treatment of BPH.
instruction: Materials and methods: A MEDLINE database search using the PRISMA methodology. Selected literature was restricted to… More >

Benjamin L. Taylor, William I. Jaffe

Canadian Journal of Urology, Vol.22, Suppl.5, pp. 24-29, 2015

Abstract instruction: Introduction: We summarize the current guidelines, techniques, efficacy and complications associated with monopolar transurethral resection of the prostate (TURP) and transurethral incision of the prostate (TUIP) for benign prostatic hyperplasia (BPH). Patients who elect to have endoscopic surgical bladder outlet reduction are faced with an abundance of evolving treatment options. As new technology comes and goes, TURP and TUIP remain the gold standard for which new treatments are compared.
instruction: Materials and methods: A review of past and contemporary data including American and European guidelines was performed. Techniques, efficacy, durability, short term and long term complications… More >

Aryeh Keehn, Franklin C. Lowe

Canadian Journal of Urology, Vol.22, Suppl.5, pp. 18-23, 2015

Abstract instruction: Introduction: The use of complementary and alternative medications has become a multi-million dollar business in the United States and comprises more than half of all filled prescriptions for benign prostatic hyperplasia (BPH) in Europe. For the practicing urologist, understanding the phytotherapeutic agents available, their proposed mechanism of action, the research supporting their use, and their safety profiles has become increasingly important as more patients inquire into their use.
instruction: Materials and methods: A comprehensive literature search was conducted to identify pertinent articles pertaining to alternative and complementary treatment options for the management of BPH. Treatments demonstrating… More >

Brandon Van Asseldonk, Jack Barkin, Dean S. Elterman

Canadian Journal of Urology, Vol.22, Suppl.5, pp. 7-17, 2015

Abstract instruction: Introduction: Benign prostatic hyperplasia (BPH) is a common disease that affects men as they age. Historically the treatment has been primarily surgical in nature, but over the past 25 years significant advances in medical therapy have been made, sparing some men from interventional procedures.
instruction: Materials and methods: This article highlights the current state-of-the-art with respect to medical therapy for lower urinary tract symptoms secondary to BPH (BPH-LUTS) including a review of landmark studies and recent areas of research in the field.
instruction: Results: Alpha blockers are considered first line when treating BPH-LUTS in men with… More >

Camille Vuichoud, Kevin R. Loughlin

Canadian Journal of Urology, Vol.22, Suppl.5, pp. 1-6, 2015

Abstract Introduction: Benign prostatic hyperplasia (BPH) is arguably the most common benign disease of mankind. As men age, the prostate inexorably grows often causing troubling symptoms causing them to seek out care. While traditionally treated by transurethral resection or open surgical removal of the hypertrophied adenoma, today the urologist has numerous medical, surgical and minimally invasive techniques available. In this supplement The Canadian Journal of Urology provides a review of the various techniques and medications available today.
Materials and methods: As an introduction to the supplement, the aim of this article is to review the epidemiology and economy… More >

Timothy D. Lyon, Katherine M. Theisen, Kevin J. Rycyna, Ronald M. Benoit

Canadian Journal of Urology, Vol.22, No.1, pp. 7674-7676, 2015

Abstract Fibrin sealants are widely used during partial nephrectomy, however reports regarding the potential complications associated with their use are limited. We present the case of a 67-year-old male who developed delayed ureteral obstruction without hydronephrosis following partial nephrectomy in a solitary kidney. We hypothesize that the obstruction and absence of hydronephrosis were caused by extrinsic compression and subsequent inflammation due to the fibrin glue. Our report underscores the importance of a high index of suspicion for obstruction when acute kidney injury occurs following partial nephrectomy when fibrin glue is used, even in the absence of More >

Duncan R. Morhardt, Lindsey Cox, John T. Stoffel

Canadian Journal of Urology, Vol.22, No.1, pp. 7671-7673, 2015

Abstract A 48-year-old man presented for evaluation of an expanding abdominal mass. Twenty years earlier, he had developed Fournier’s gangrene requiring extensive debridement. He underwent augmentation cystoplasty with a catheterizable stoma due to a proximal urethral stricture. Fifteen years later, he was found to have a 14 cm x 18 cm bladder augment calculus. Simpson obstetric forceps were passed into the augment to deliver a 1110 gram stone with minimal devitalization of the colonic augmentation tissue. This is the first report of stone management with obstetric forceps in an augmented bladder. The specimen itself is among More >

Mark W. Ball, Michael A. Gorin, Gautam Jayram, Phillip M. Pierorazio, Mohamad E. Allaf

Canadian Journal of Urology, Vol.22, No.1, pp. 7666-7670, 2015

Abstract Introduction: To describe our technique for robot-assisted radical nephrectomy (RARN) with inferior vena cava (IVC) tumor thrombectomy and to present initial results for our first two patients.
Materials and methods: Two patients with renal masses with infrahepatic IVC extension underwent RARN with IVC tumor thrombectomy using a four-arm configuration. Both cases were right-sided tumors. Vascular control was obtained with complete cross-clamping of the vena cava with robotic bulldog clamps. Intraoperative ultrasound was used to delineate extent of tumor extension. Specimens were removed en-bloc, and the IVC was closed with 2-layers of 4-0 Prolene. The specimen is extracted… More >

Lior M. Hirsch¹, Michael J. Amirian¹, Scott G. Hubosky¹, Akhil K. Das¹, Babak Abai², Costas D. Lallas¹

Canadian Journal of Urology, Vol.22, No.1, pp. 7661-7665, 2015

Abstract Patients with a uretero-iliac artery fistula (UIAF) are at an elevated risk of life-threatening hemorrhage. Identification and treatment of the fistula may be challenging, and requires the combined expertise of a urologist and endovascular specialist. This manuscript provides a list of equipment needed and describes our technique for diagnosing and treating a UIAF. More >